Evolent Health Management
Management Kriterienprüfungen 2/4
Evolent Health CEO ist Seth Blackley , ernannt in Jan 2011, hat eine Amtszeit von 13.83 Jahren. Die jährliche Gesamtvergütung beträgt $8.93M , bestehend aus 8.8% Gehalt und 91.2% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.27% der Aktien des Unternehmens, im Wert von $3.60M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.7 Jahre bzw. 4.4 Jahre.
Wichtige Informationen
Seth Blackley
Geschäftsführender
US$8.9m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 8.8% |
| Amtszeit als Geschäftsführer | 13.8yrs |
| Eigentum des Geschäftsführers | 0.3% |
| Durchschnittliche Amtszeit des Managements | 3.7yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 4.4yrs |
Jüngste Management Updates
Recent updates
Evolent Health: A Shot At Revival After Market Bruising
Nov 12Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper
Nov 09
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)
Nov 07Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet
Sep 19Evolent Health: Let The Bidding Begin
Aug 23Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk
Jul 29Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Jul 01Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)
May 22These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?
Feb 01Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
Jan 14Evolent spikes as Humana partnership expands
Jan 12Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?
Dec 27Evolent Health offered $23.5M class action securities settlement
Sep 19Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Sep 18Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$104m |
| Jun 30 2024 | n/a | n/a | -US$106m |
| Mar 31 2024 | n/a | n/a | -US$141m |
| Dec 31 2023 | US$9m | US$783k | -US$142m |
| Sep 30 2023 | n/a | n/a | -US$112m |
| Jun 30 2023 | n/a | n/a | -US$77m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$8m | US$683k | -US$19m |
| Sep 30 2022 | n/a | n/a | -US$4m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$24m |
| Dec 31 2021 | US$7m | US$600k | -US$30m |
| Sep 30 2021 | n/a | n/a | -US$45m |
| Jun 30 2021 | n/a | n/a | -US$68m |
| Mar 31 2021 | n/a | n/a | -US$261m |
| Dec 31 2020 | US$4m | US$438k | -US$328m |
| Sep 30 2020 | n/a | n/a | -US$515m |
| Jun 30 2020 | n/a | n/a | -US$504m |
| Mar 31 2020 | n/a | n/a | -US$334m |
| Dec 31 2019 | US$3m | US$400k | -US$304m |
| Sep 30 2019 | n/a | n/a | -US$121m |
| Jun 30 2019 | n/a | n/a | -US$107m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | US$2m | US$400k | -US$53m |
| Sep 30 2018 | n/a | n/a | -US$49m |
| Jun 30 2018 | n/a | n/a | -US$49m |
| Mar 31 2018 | n/a | n/a | -US$56m |
| Dec 31 2017 | US$2m | US$400k | -US$61m |
Vergütung im Vergleich zum Markt: SethDie Gesamtvergütung ($USD8.93M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.43M).
Entschädigung vs. Einkommen: SethDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
Geschäftsführer
Seth Blackley (45 yo)
13.8yrs
Amtszeit
US$8,931,188
Vergütung
Mr. Seth Barrie Blackley is Director of Iodine Software, LLC. He serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True H...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$8.93m | 0.27% $ 3.6m | |
| President | 2.2yrs | US$5.76m | 0.16% $ 2.2m | |
| Chief Financial Officer | 5.3yrs | US$3.53m | 0.15% $ 2.0m | |
| Chief Operating Officer | 1.3yrs | US$2.69m | 0.055% $ 734.8k | |
| Chief Legal Officer | 10.8yrs | US$2.01m | 0.11% $ 1.4m | |
| Chief Accounting Officer | 4.4yrs | US$634.88k | 0.020% $ 264.5k | |
| Senior Vice President of Corporate Finance | less than a year | keine Daten | keine Daten | |
| Chief Technology Officer | no data | keine Daten | keine Daten | |
| Chief Information Officer | less than a year | keine Daten | keine Daten | |
| Vice President of Investor Relations | 2.9yrs | keine Daten | keine Daten | |
| Chief Strategy Officer | 12.8yrs | keine Daten | keine Daten | |
| President of Performance Suite | no data | keine Daten | keine Daten |
3.7yrs
Durchschnittliche Betriebszugehörigkeit
40.5yo
Durchschnittliches Alter
Erfahrenes Management: EVHDas Führungsteam des Unternehmens gilt als erfahren (3.7 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Co-Founder | 6.6yrs | US$8.93m | 0.27% $ 3.6m | |
| Independent Director | 4.8yrs | US$260.25k | 0.036% $ 485.8k | |
| Independent Director | 1.4yrs | US$245.50k | 0.0059% $ 78.3k | |
| Independent Director | less than a year | keine Daten | 0.0053% $ 70.1k | |
| Independent Chairperson of the Board & Lead Independent Director | 9yrs | US$347.75k | 0.038% $ 507.5k | |
| Independent Director | 13.3yrs | US$265.25k | 0.048% $ 638.4k | |
| Independent Director | 7.2yrs | US$255.25k | 0.035% $ 467.0k | |
| Independent Director | 3.8yrs | US$265.25k | 0.018% $ 246.5k | |
| Independent Director | 3.9yrs | US$257.50k | 0.019% $ 257.8k | |
| Independent Director | 1.3yrs | US$195.83k | 0% $ 0 |
4.4yrs
Durchschnittliche Betriebszugehörigkeit
59yo
Durchschnittliches Alter
Erfahrener Vorstand: EVHDie Vorstandsmitglieder gelten als erfahren (4.4 Jahre durchschnittliche Amtszeit).